JFNAX Holdings — Janus Henderson Global Life Sciences Fund
All 104 reported holdings of Janus Henderson Global Life Sciences Fund (JFNAX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 9.41% | $546.44M |
| Johnson & Johnson | 7.09% | $411.81M |
| AbbVie, Inc. | 4.67% | $271.02M |
| UnitedHealth Group, Inc. | 4.54% | $263.63M |
| AstraZeneca plc | 3.93% | $228.27M |
| Revolution Medicines, Inc. | 3.02% | $175.40M |
| Argenx SE | 2.63% | $152.70M |
| Novartis AG | 2.56% | $148.84M |
| Thermo Fisher Scientific, Inc. | 2.33% | $135.41M |
| Praxis Precision Medicines, Inc. | 2.19% | $127.00M |
| Bridgebio Pharma, Inc. | 2.04% | $118.45M |
| CVS Health Corp. | 2.02% | $117.16M |
| Roche Holding AG | 2.01% | $116.93M |
| Intuitive Surgical, Inc. | 1.94% | $112.90M |
| Merck & Co., Inc. | 1.87% | $108.84M |
| Abbott Laboratories | 1.86% | $108.26M |
| Vertex Pharmaceuticals, Inc. | 1.69% | $98.28M |
| Ascendis Pharma A/S | 1.68% | $97.47M |
| Danaher Corp. | 1.65% | $95.71M |
| Amgen, Inc. | 1.64% | $95.14M |
| Sanofi SA | 1.58% | $91.80M |
| Stryker Corp. | 1.41% | $82.01M |
| PTC Therapeutics, Inc. | 1.40% | $81.21M |
| Gilead Sciences, Inc. | 1.39% | $80.53M |
| Travere Therapeutics, Inc. | 1.38% | $80.28M |
| Madrigal Pharmaceuticals, Inc. | 1.34% | $78.05M |
| HCA Healthcare, Inc. | 1.26% | $73.46M |
| Mirum Pharmaceuticals, Inc. | 1.13% | $65.44M |
| Boston Scientific Corp. | 1.12% | $65.34M |
| Teva Pharmaceutical Industries Ltd. | 1.10% | $63.80M |
| United Therapeutics Corp. | 1.07% | $62.20M |
| Elevance Health, Inc. | 1.04% | $60.56M |
| Globus Medical, Inc. | 1.01% | $58.82M |
| Lantheus Holdings, Inc. | 0.97% | $56.41M |
| McKesson Corp. | 0.96% | $55.77M |
| Vaxcyte, Inc. | 0.94% | $54.79M |
| Dyne Therapeutics, Inc. | 0.87% | $50.48M |
| Edwards Lifesciences Corp. | 0.78% | $45.31M |
| Medtronic plc | 0.74% | $42.99M |
| Janus Henderson Cash Liquidity Fund LLC | 0.70% | $40.50M |
| Cencora, Inc. | 0.60% | $34.88M |
| Ucb SA | 0.58% | $33.84M |
| Medline, Inc. | 0.58% | $33.57M |
| Definium Therapeutics, Inc. | 0.58% | $33.41M |
| Insmed, Inc. | 0.56% | $32.58M |
| Dexcom, Inc. | 0.54% | $31.12M |
| Structure Therapeutics, Inc. | 0.51% | $29.48M |
| Spyre Therapeutics, Inc. | 0.50% | $29.17M |
| Ideaya Biosciences, Inc. | 0.49% | $28.24M |
| Apogee Therapeutics, Inc. | 0.47% | $27.53M |
| Glaukos Corp. | 0.47% | $27.53M |
| Edgewise Therapeutics, Inc. | 0.47% | $27.51M |
| Becton Dickinson & Co. | 0.46% | $26.62M |
| Abivax SA | 0.41% | $23.87M |
| Neurocrine Biosciences, Inc. | 0.39% | $22.74M |
| Tarsus Pharmaceuticals, Inc. | 0.38% | $21.82M |
| Centene Corp. | 0.37% | $21.21M |
| Oruka Therapeutics, Inc. | 0.36% | $21.14M |
| Curevo, Inc. | 0.35% | $20.19M |
| Xenon Pharmaceuticals, Inc. | 0.35% | $20.16M |
| Cogent Biosciences, Inc. | 0.35% | $20.10M |
| Biohaven Ltd. | 0.34% | $19.84M |
| Cooper Cos., Inc. (The) | 0.33% | $19.12M |
| Jp Morgan | 0.32% | $18.35M |
| Tango Therapeutics, Inc. | 0.32% | $18.33M |
| HeartFlow, Inc. | 0.31% | $18.13M |
| Sotera Health Co. | 0.31% | $17.99M |
| Scholar Rock Holding Corp. | 0.31% | $17.89M |
| Insulet Corp. | 0.30% | $17.70M |
| Rhythm Pharmaceuticals, Inc. | 0.30% | $17.56M |
| Humana, Inc. | 0.30% | $17.52M |
| STERIS plc | 0.29% | $16.66M |
| Illumina, Inc. | 0.28% | $16.31M |
| Jade Biosciences, Inc. | 0.27% | $15.93M |
| Daiichi Sankyo Co. Ltd. | 0.27% | $15.51M |
| Penumbra, Inc. | 0.26% | $15.01M |
| Mirum Pharmaceuticals, Inc. | 0.25% | $14.49M |
| Protagonist Therapeutics, Inc. | 0.25% | $14.42M |
| Crinetics Pharmaceuticals, Inc. | 0.24% | $14.11M |
| Regeneron Pharmaceuticals, Inc. | 0.24% | $13.80M |
| Alnylam Pharmaceuticals, Inc. | 0.21% | $12.44M |
| Kardium, Inc. | 0.21% | $12.24M |
| Teleflex, Inc. | 0.20% | $11.75M |
| Ardelyx, Inc. | 0.19% | $11.09M |
| 4D Molecular Therapeutics, Inc. | 0.18% | $10.49M |
| Parabilis Medicines, Inc. | 0.15% | $8.57M |
| Olema Pharmaceuticals, Inc. | 0.14% | $8.23M |
| Royal Bank Of Canada | 0.09% | $5.04M |
| Euro | 0.08% | $4.45M |
| Magnolia Medical Technologies, Inc. | 0.05% | $2.92M |
| Lexeo Therapeutics, Inc. | 0.04% | $2.61M |
| Element Biosciences, Inc. | 0.04% | $2.46M |
| Freenome Holdings, Inc. | 0.04% | $2.04M |
| Janus Henderson Cash Collateral Fund LLC | 0.03% | $1.98M |
| Pfizer, Inc. | 0.03% | $1.92M |
| Twinstrand Biosciences, Inc. | 0.02% | $1.38M |
| Asher Biotherapeutics, Inc. | 0.02% | $1.19M |
| Sonoma Biotherapeutics, Inc. | 0.02% | $985.33K |
| Jpm | 0.01% | $525.50K |
| Attralus, Inc. | 0.01% | $415.36K |
| Novo Nordisk A/S | 0.01% | $370.03K |
| Alkermes plc | 0.01% | $288.13K |
| Yen | 0.00% | $226.17K |
JFNAX overview: performance, fees, allocation and SEC filings